Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes [Phase 2]
Phase 2 trial update on lenalidomide monotherapy for myelodysplastic syndromes, reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen [Phase 2]
Phase 2 clinical trial evaluating a clofarabine and busulfan conditioning regimen before stem cell transplantation for leukemia and myelodys…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [Phase 3]
A completed Phase 3 trial evaluating an antifungal therapy for fever and neutropenia in patients undergoing treatment for hematologic cancer…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation after conditioning with busulfan, fludarabine, and antithymocyte globulin in patien…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Phase 1, Phase 2]
This Phase 1/2 trial evaluates a combination chemotherapy regimen followed by peripheral stem cell transplantation in patients with refracto…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease [NA]
This completed clinical trial examines donor stem cell transplantation after conditioning therapy in patients with hematologic cancers, recu…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Belinostat in Treating Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial update showing completed results for belinostat in myelodysplastic syndromes with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 2, Phase 3]
This clinical trial update describes the Phase 2/Phase 3 evaluation of decitabine as an adjunct after allogeneic stem cell transplantation i…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow transplantation in advanced hematologic cancers. The tria…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluates differentiation therapy with decitabine in patients with myelodysplastic syndromes and related conditio…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of bortezomib combined with vorinostat in high-risk myelodysplastic syndrome or acute myeloid leukemia has been terminated; re…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]
A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hema…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Stem Cell Transplantation for Hematological Malignancies [Phase 2, Phase 3]
This clinical trial update reports termination of a Phase 2/Phase 3 study evaluating stem cell transplantation for hematologic malignancies.…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]
This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders [Phase 1]
Phase 1 study assessing decitabine with FR901228 (romidepsin) in patients with relapsed or refractory leukemia, myelodysplastic syndromes, a…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
NCI-sponsored Phase 1 clinical trial update of 6-Hydroxymethylacylfulvene (Irofulven) in patients with refractory acute myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Phase 1, Phase 2]
This clinical trial update indicates termination of a Phase 1/2 study evaluating arsenic trioxide with or without tretinoin in patients with…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
This update notes the completion of a Phase 1/2 trial of darbepoetin alfa in patients with myelodysplastic syndromes.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 clinical study evaluating sequential administration of Interleukin-12 followed by Interferon alfa in adults with advanced cancer; th…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating thalidomide for anemia in patients with myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]
A Phase 1/2 study evaluated the safety and preliminary efficacy of combining amifostine with topotecan in patients with leukemia and myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Thalidomide in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial of thalidomide for chronic myelomonocytic leukemia and myelodysplastic syndromes has completed. The study investigated thalido…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating a rebeccamycin analog in adults with relapsed or refractory acute myeloid leukemia, myelodysplastic syndromes, acut…